CIAS
ACET icon

Capital Investment Advisory Services’s Adicet Bio ACET Stock Holding History

Capital Investment Advisory Services’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2
Closed -$2K – 556
2019
Q3 		$2K Hold
2
– – ﹤0.01% 1249
2019
Q2 		$2K Buy
+2
New +$1.81K ﹤0.01% 1257

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital Investment Advisory Services's ACET Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Adicet Bio (ACET) in Q4 2019, closing a stake of 2 shares — an estimated $2K sold.

Capital Investment Advisory Services first reported a position in ACET in Q2 2019 and held it in 2 quarters. The position peaked at $2K in Q3 2019. 54 funds tracked by Wall St. Rank hold ACET as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Adicet Bio position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 2 Adicet Bio shares in Q4 2019, an estimated $2K.
  • Capital Investment Advisory Services first reported a position in Adicet Bio in Q2 2019 and held it in 2 quarters.
  • Capital Investment Advisory Services's Adicet Bio position peaked at $2K in Q3 2019.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.